Skip to content
10-Q

Quarterly Report

SCICLONE PHARMACEUTICALS INC

0000880771-17-000079

← back to feed
Filed
May 10, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2017 · May 5, 2017 51.73M sh
Shares Diluted Q1 2017 · Mar 31, 2017 53.01M sh
Shares Diluted Q1 2017 · Mar 31, 2016 51.96M sh
Capex Q1 2017 · Mar 31, 2017 $65K
Capex Q1 2017 · Mar 31, 2016 $20K
Cash And Equivalents Q1 2017 · Mar 31, 2017 $141.35M
Cash And Equivalents Q1 2017 · Dec 31, 2016 $134.4M
Cash And Equivalents Q1 2017 · Mar 31, 2016 $114.69M
Cash And Equivalents Q1 2017 · Dec 31, 2015 $101.4M
Stockholders Equity Q1 2017 · Mar 31, 2017 $233.38M
Stockholders Equity Q1 2017 · Dec 31, 2016 $215.37M
Current Liabilities Q1 2017 · Mar 31, 2017 $20.02M
Current Liabilities Q1 2017 · Dec 31, 2016 $26.44M
Current Assets Q1 2017 · Mar 31, 2017 $207.14M
Current Assets Q1 2017 · Dec 31, 2016 $195.73M
Total Assets Q1 2017 · Mar 31, 2017 $253.48M
Total Assets Q1 2017 · Dec 31, 2016 $241.9M
Eps Diluted Q1 2017 · Mar 31, 2017 $0.28
Eps Diluted Q1 2017 · Mar 31, 2016 $0.15
Eps Basic Q1 2017 · Mar 31, 2017 $0.28
Eps Basic Q1 2017 · Mar 31, 2016 $0.16
Sga Expense Q1 2017 · Mar 31, 2017 $7.23M
Sga Expense Q1 2017 · Mar 31, 2016 $7.44M
Net Income Q1 2017 · Mar 31, 2017 $14.6M
Net Income Q1 2017 · Mar 31, 2016 $7.86M
Operating Income Q1 2017 · Mar 31, 2017 $14.24M
Operating Income Q1 2017 · Mar 31, 2016 $9.42M
Revenue Q1 2017 · Mar 31, 2017 $42.89M
Revenue Q1 2017 · Mar 31, 2016 $36.5M